PROFUND ADVISORS LLC

Position in RGNX — REGENXBIO Inc.

CIK 1129919 BETHESDA, MD

Position in RGNX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$329,282

+$52,365 QoQ

Shares Held

27,486

-16.8% QoQ

Ownership

0.042%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#84

of 163 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. RGNX ranks #126 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$329,282	27,486	-16.8%	Shares	Sole	2026-08-11
2026-03-31	$276,917	33,045	+48.5%	Shares	Sole	2026-04-27
2025-12-31	$320,414	22,251	+54.1%	Shares	Sole	2026-02-06
2025-09-30	$139,384	14,444	+11.8%	Shares	Sole	2025-11-06
2025-06-30	$106,081	12,921	-29.2%	Shares	Sole	2025-08-07
2024-12-31	$141,118	18,256	+8.3%	Shares	Sole	2025-02-14
2024-09-30	$176,840	16,858	-18.2%	Shares	Sole	2024-11-14
2024-06-30	$241,101	20,607	-30.1%	Shares	Sole	2024-08-13
2024-03-31	$621,565	29,500	+36.3%	Shares	Sole	2024-05-08
2023-12-31	$388,617	21,650	-9.5%	Shares	Sole	2024-02-14
2023-09-30	$393,838	23,927	-20.7%	Shares	Sole	2023-11-13
2023-06-30	$603,118	30,171	+17.3%	Shares	Sole	2023-08-10
2023-03-31	$486,346	25,719	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.